E-LIB Suche - Ergebnisse für: Drysdale, Claire M.

1

Cas9 protein delivery non-integrating lentiviral vectors fo..:

Uchida, Naoya ; Drysdale, Claire M. ; Nassehi, Tina...
Molecular Therapy - Methods & Clinical Development. 21 (2021) - p. 121-132 , 2021

Link: https://doi.org/10.1016/..

2

Preclinical evaluation for engraftment of CD34+ cells gene-..:

Uchida, Naoya ; Li, Linhong ; Nassehi, Tina...
Cell Reports Medicine. 2 (2021) 4 - p. 100247 , 2021

Link: https://doi.org/10.1016/..

3

Immunoresponse to Gene-Modified Hematopoietic Stem Cells:

Drysdale, Claire M. ; Tisdale, John F. ; Uchida, Naoya
Molecular Therapy - Methods & Clinical Development. 16 (2020) - p. 42-49 , 2020

Link: https://doi.org/10.1016/..

4

Ex vivo immunological evaluation of stable mixed chimeric p..:

Raines, Lydia N. ; Hsieh, Matthew M. ; Nassehi, Tina...
Cytotherapy. 21 (2019) 12 - p. 1206-1215 , 2019

Link: https://doi.org/10.1016/..

5

Busulfan Combined with Immunosuppression Allows Efficient E..:

Uchida, Naoya ; Nassehi, Tina ; Drysdale, Claire M....
Molecular Therapy. 27 (2019) 9 - p. 1586-1596 , 2019

Link: https://doi.org/10.1016/..

6

Low-Dose Busulfan Reduces Human CD34+ Cell Doses Required f..:

Leonard, Alexis ; Yapundich, Morgan ; Nassehi, Tina...
Molecular Therapy - Methods & Clinical Development. 15 (2019) - p. 430-437 , 2019

Link: https://doi.org/10.1016/..

7

High-Efficiency Lentiviral Transduction of Human CD34+ Cell..:

Uchida, Naoya ; Nassehi, Tina ; Drysdale, Claire M....
Molecular Therapy - Methods & Clinical Development. 13 (2019) - p. 187-196 , 2019

Link: https://doi.org/10.1016/..

8

Cas9 protein delivery non-integrating lentiviral vectors fo..:

Uchida, Naoya ; Drysdale, Claire M ; Nassehi, Tina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005818/. , 2021

Link: http://www.ncbi.nlm.nih...

9

Preclinical evaluation for engraftment of CD34(+) cells gen..:

Uchida, Naoya ; Li, Linhong ; Nassehi, Tina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080237/. , 2021

Link: http://www.ncbi.nlm.nih...

10

High-Efficiency Lentiviral Transduction of Human CD34+ Cell..:

Uchida, Naoya ; Nassehi, Tina ; Drysdale, Claire M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370599/. , 2019

Link: http://www.ncbi.nlm.nih...

11

Low-Dose Busulfan Reduces Human CD34(+) Cell Doses Required..:

Leonard, Alexis ; Yapundich, Morgan ; Nassehi, Tina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909187/. , 2019

Link: http://www.ncbi.nlm.nih...

12

Cas9 protein delivery non-integrating lentiviral vectors fo..:

Naoya Uchida ; Claire M. Drysdale ; Tina Nassehi...
http://www.sciencedirect.com/science/article/pii/S2329050121000371. , 2021

Link: https://doi.org/10.1016/..

13

Preclinical evaluation for engraftment of CD34+ cells gene-..:

Naoya Uchida ; Linhong Li ; Tina Nassehi...
http://www.sciencedirect.com/science/article/pii/S266637912100063X. , 2021

Link: https://doi.org/10.1016/..

14

Immunoresponse to Gene-Modified Hematopoietic Stem Cells:

Claire M. Drysdale ; John F. Tisdale ; Naoya Uchida
http://www.sciencedirect.com/science/article/pii/S2329050119301184. , 2020

Link: https://doi.org/10.1016/..

15

High-Efficiency Lentiviral Transduction of Human CD34+ Cell..:

Naoya Uchida ; Tina Nassehi ; Claire M. Drysdale...
http://www.sciencedirect.com/science/article/pii/S2329050119300087. , 2019

Link: https://doi.org/10.1016/..